Código QR (código de barras bidimensional)

Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?

Assessing progression of disease or response to treatment remains a major challenge in the clinical management of nontuberculous mycobacterial (NTM) infections of the lungs. Serial assessments of validated measures of treatment response address whether the current therapeutic approach is on track to...

ver descrição completa

Na minha lista:
Principais autores: Christopher Vinnard, Alyssa Mezochow, Hannah Oakland, Ross Klingsberg, John Hansen-Flaschen, Keith Hamilton
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018-11-01
coleção:Frontiers in Microbiology
Assuntos:
nontuberculous mycobactena
biomarker (development)
response
therapeutics
clinical trial
radiography
Acesso em linha:https://www.frontiersin.org/article/10.3389/fmicb.2018.02813/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados